Alberto-Culver divests in name of beauty
This article was originally published in The Rose Sheet
Executive Summary
Alberto-Culver will sell wholly-owned subsidiary Cederroth International to Nordic-based private equity firm CapMan, allowing it to focus on growing core beauty care brands TRESemme, Nexxus, Alberto VO5 and St. Ives, firm announces May 19. Cederroth, based in Stockholm, Sweden, manufactures and markets consumer products in the Nordic region and parts of Europe, with only "a portion" of its brands competing in the beauty-care category, Alberto-Culver says. Under terms of the deal, a fund managed by CapMan will purchase all outstanding Cederroth capital stock; transaction is expected to close this summer pending regulatory approval...
You may also be interested in...
US FDA Expects Joint AdComm Briefing Document, Oncology Chief Says
The combined format is the new default for briefing advisory committee members, US FDA Oncology Center of Excellence Director Pazdur declared.
Parallel Scientific Advice: Is The EMA User Fee Impacting Interest?
EMA charges participants to receive scientific advice through the fledgling program, unlike the US FDA, which may not fit the budgets of some complex generic sponsors. At the same time, sponsors also may simply not be aware the program exists yet.
Medicare-Negotiated Drugs May Not Get Favorable Coverage In Part D: Will CMS Intervene?
Insurance plans put on notice that CMS is concerned about restrictions on drugs with negotiated prices, but it’s not clear what the agency can or will do about it.